Clinical Trial Update: Inhalation SLIT Cisplatin (Liposomal) for the Treatment of Osteosarcoma Metastatic to the Lung [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating inhaled liposomal cisplatin for metastatic osteosarcoma to the lung has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma
• Osteosarcoma with Pulmonary Metastases

Drugs mentioned

• Cisplatin liposomal inhalation (cisplatin)

Snippet

Sponsor: Insmed Incorporated | Conditions: Osteosarcoma Metastatic | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-08-01